<p>The clearance of the following proteins is determined in bone marrow FcRn chimeric mice. (A) rFVIII (250 IU/kg), which clearance is not affected by FcRn (B) rFVIIIFc (250 IU/kg) which is predominantly protected from clearance by FcRn expressed in somatic cells (KO→WT). (C) rFIXFc (250 IU/kg) is mostly protected from clearance by FcRn expressed in somatic cells (KO→WT) (D) human IgG1 (5 mg/kg) is protected from clearance by FcRn expressed in hematopoietic cells (WT→KO). Plasma levels measured at 5 minute are set to 100% and the calculated mean residence times (MRT) are show in the graph insert, n = 4 for each data-point. Significance between plasma levels for individual time points on the PK curves is determined by an unpaired 2-tailed st...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
Abstract Antibody-based therapeutics (ABTs) are used to treat a range of diseases. Most ABTs are eit...
<p>(A-C) Quantitation of the radioactivity remaining in perfused organs for <sup>125</sup>I-rFVIII a...
The neonatal Fc receptor (FcRn) has been demonstrated to contribute to a high bioavailability of mon...
The MHC class l-related receptor FcRn regulates the levels and persistence of IgG in vivo. This rece...
The major histocompatibility complex (MHC) class l-related receptor FcRn is involved in regulating s...
A key element for the successful development of novel therapeutic antibodies is to fully understand ...
Mice genetically engineered to express human FcRn are valuable models for the evaluation of therapeu...
We recently developed a longer lasting recombinant factor VIII-Fc fusion protein, rFVIIIFc, to exten...
Quantitative real-time PCR and Western blot methods were developed to assess neonatal Fc-receptor (F...
We recently developed a longer lasting recombinant factor VIII-Fc fusion protein, rFVIIIFc, to exten...
The importance of therapeutic recombinant proteins in medicine has led to a variety of tactics to in...
The analysis of the pharmacokinetics of wild-type and mutated Fc fragments derived from human IgG1 i...
The neonatal FcR (FcRn) is a receptor that protects IgG from catabolism and is important in maintain...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
Abstract Antibody-based therapeutics (ABTs) are used to treat a range of diseases. Most ABTs are eit...
<p>(A-C) Quantitation of the radioactivity remaining in perfused organs for <sup>125</sup>I-rFVIII a...
The neonatal Fc receptor (FcRn) has been demonstrated to contribute to a high bioavailability of mon...
The MHC class l-related receptor FcRn regulates the levels and persistence of IgG in vivo. This rece...
The major histocompatibility complex (MHC) class l-related receptor FcRn is involved in regulating s...
A key element for the successful development of novel therapeutic antibodies is to fully understand ...
Mice genetically engineered to express human FcRn are valuable models for the evaluation of therapeu...
We recently developed a longer lasting recombinant factor VIII-Fc fusion protein, rFVIIIFc, to exten...
Quantitative real-time PCR and Western blot methods were developed to assess neonatal Fc-receptor (F...
We recently developed a longer lasting recombinant factor VIII-Fc fusion protein, rFVIIIFc, to exten...
The importance of therapeutic recombinant proteins in medicine has led to a variety of tactics to in...
The analysis of the pharmacokinetics of wild-type and mutated Fc fragments derived from human IgG1 i...
The neonatal FcR (FcRn) is a receptor that protects IgG from catabolism and is important in maintain...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
We previously produced a recombinant version of the human anti-RhD antibody Fog-1 in the rat myeloma...
Abstract Antibody-based therapeutics (ABTs) are used to treat a range of diseases. Most ABTs are eit...
<p>(A-C) Quantitation of the radioactivity remaining in perfused organs for <sup>125</sup>I-rFVIII a...